中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
The androgen receptor in hormone-refractory prostate cancer

文献类型:期刊论文

作者Mao, HL; Zhu, ZQ; Chen, CD
刊名ASIAN JOURNAL OF ANDROLOGY
出版日期2009
卷号11期号:1页码:68-73
关键词prostate cancer hormone therapy androgen receptor hormone-refractory prostate cancer
通讯作者Chen, CD (reprint author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai Key Lab Androl,State Key Lab Mol Biol, 320 Yueyang Rd, Shanghai 200031, Peoples R China.,cdchen@sibs.ac.cn
英文摘要Advanced prostate cancer is responsive to hormone therapy that interferes with androgen receptor (AR) signalling. However, the effect is short-lived, as nearly all tumours progress to a hormone-refractory (HR) state, a lethal stage of the disease. Intuitively, the AR should not be involved because hormone therapy that blocks or reduces AR activity is not effective in treating HR tumours. However, there is still a consensus that AR plays an essential role in HR prostate cancer (HRPC) because AR signalling is still functional in HR tumours. AR signalling can be activated in HR tumours through several mechanisms. First, activation of intracellular signal transduction pathways can sensitize the AR to castrate levels of androgens. Also, mutations in the AR can change AR ligand specificity, thereby allowing it to be activated by non-steroids or anti-androgens. Finally, overexpression of the wild-type AR sensitizes itself to low concentrations of androgens. Therefore, drugs targeting AR signalling could still be effective in treating HRPC.
学科主题Endocrinology & Metabolism; Urology & Nephrology
类目[WOS]Andrology ; Urology & Nephrology
关键词[WOS]STEROID BINDING CHARACTERISTICS ; GROWTH-FACTOR-I ; INCREASED EXPRESSION ; CELLS ; GENE ; AMPLIFICATION ; ACTIVATION ; CARCINOMA ; MUTATION ; THERAPY
收录类别SCI
语种英语
WOS记录号WOS:000262866800010
版本出版稿
源URL[http://202.127.25.143/handle/331003/1125]  
专题上海生化细胞研究所_上海生科院生化细胞研究所
推荐引用方式
GB/T 7714
Mao, HL,Zhu, ZQ,Chen, CD. The androgen receptor in hormone-refractory prostate cancer[J]. ASIAN JOURNAL OF ANDROLOGY,2009,11(1):68-73.
APA Mao, HL,Zhu, ZQ,&Chen, CD.(2009).The androgen receptor in hormone-refractory prostate cancer.ASIAN JOURNAL OF ANDROLOGY,11(1),68-73.
MLA Mao, HL,et al."The androgen receptor in hormone-refractory prostate cancer".ASIAN JOURNAL OF ANDROLOGY 11.1(2009):68-73.

入库方式: OAI收割

来源:上海生物化学与细胞生物学研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。